CERVICAL cancer is the fourth most common cancer in Jamaica, and the second leading cause of cancer-related deaths among Jamaican women. But it is considered a preventable disease, and ...

During a live event, Shannon N. Westin, MD, MPH, and participants discussed their experience treating patients with ...

He expressed concern that every year in Nigeria, more than 12,000 women suffer from cervical cancer, saying the disease is preventable. Prof. Pate noted that President Bola Tinubu was committed to ...

For most screenable cancers, a pandemic-related surge of late-stage diagnoses in 2020 quickly returned to pre-pandemic levels in 2021, with the exception of cervical cancer.  According to the National ...

Each year, millions of people attend cervical screening appointments to help prevent cervical cancer, the most common cancer in women under 35 years old. However, many don’t come forward and ...

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

A parasitic worm may raise the risk of cervical cancer through several mechanisms, scientists have found, although HPV ...

“It’s a bone cancer awareness bracelet, but I purchased them for my team,” O’Toole said. That’s how the High Point Police Department is reminding Coleman they are in this journey together.

According to a 2024 report by the Department of Health and Aged Care, cervical cancer is diagnosed in around 800 Australian women each year - and there are barely any symptoms. Shockingly ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Tivdak is a first-in-class therapy that combines an antibody target at tissue factor – a protein expressed on cervical cancer cells – with a cell-killing drug called monomethyl auristatin E.

Background: Androgen ablation is often used in addition to low-dose-rate brachytherapy in the treatment of prostate cancer, particularly for disease with adverse features. We report a single ...